0001140361-24-000498.txt : 20240103 0001140361-24-000498.hdr.sgml : 20240103 20240103180626 ACCESSION NUMBER: 0001140361-24-000498 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pepose Jay CENTRAL INDEX KEY: 0001866191 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34079 FILM NUMBER: 24508688 MAIL ADDRESS: STREET 1: 37000 GRAND RIVER AVE STREET 2: SUITE 120 CITY: FARMINGTON HILLS STATE: MI ZIP: 48335 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ocuphire Pharma, Inc. CENTRAL INDEX KEY: 0001228627 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 113516358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 37000 GRAND RIVER AVE. STREET 2: SUITE 120 CITY: FARMINGTON HILLS STATE: MI ZIP: 48335 BUSINESS PHONE: 248-681-9815 MAIL ADDRESS: STREET 1: 37000 GRAND RIVER AVE. STREET 2: SUITE 120 CITY: FARMINGTON HILLS STATE: MI ZIP: 48335 FORMER COMPANY: FORMER CONFORMED NAME: REXAHN PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20050516 FORMER COMPANY: FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC DATE OF NAME CHANGE: 20030423 4 1 form4.xml X0508 4 2024-01-01 0001228627 Ocuphire Pharma, Inc. OCUP 0001866191 Pepose Jay C/O OCUPHIRE PHARMA, INC. 37000 GRAND RIVER AVE, SUITE 120 FARMINGTON HILLS MI 48335 true false Common Stock 2024-01-01 4 A 0 14964 A 107315 D The Reporting Person was granted shares of common stock in lieu of cash for board services for 2024. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $2.81 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to January 1, 2024. /s/ Emily Johns, by Power of Attorney 2024-01-03